Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Ovarian Neoplasms 13Prostatic Neoplasms 7Fallopian Tube Neoplasms 5Neoplasms 3Neoplasm Metastasis 3Breast Neoplasms 3Prostatic Neoplasms, Castration-Resistant 2Glioblastoma 2Endometrial Neoplasms 2Carcinoma, Ovarian Epithelial 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1SCLC,Extensive Stage 1Pathologic Complete Response 1Pancreatic Neoplasms 1Ovarian Carcinosarcoma 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1Metastatic Castration-sensitive Prostate Cancer 1Lung Neoplasms 1Laryngeal Diseases 1Hereditary Sensory and Autonomic Neuropathies 1Hemangiosarcoma 1Head and Neck Neoplasms 1Glioma 1Disease Progression 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 22Magnetic Resonance Spectroscopy 15Specimen Handling 13Platinum 12Radiotherapy, Intensity-Modulated 111,2-diaminocyclohexaneplatinum II citrate 11Radiotherapy 10Radiation 10Carboplatin 9Surveys and Questionnaires 5Biopsy 5pembrolizumab 4Taxes 4Paclitaxel 4Nivolumab 4Docetaxel 4Chemoradiotherapy 4Cetuximab 4Observation 3Fluorodeoxyglucose F18 3(225)Ac-DOTA-c(RGDyK) 3durvalumab 2X-Rays 2Watchful Waiting 2Standard of Care 2Radiotherapy, Image-Guided 2Interviews as Topic 2Immunoglobulin G 2Fluorouracil 2Disulfides 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × niraparib × 90 days × Clear all
NCT05784012 2026-06-04

RADIAN

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Phase 1/2 Active not recruiting
34 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡